diff --git a/src/data/drug-data.tsx b/src/data/drug-data.tsx
index b64f14f16f7e9389114b1f2cde94415fb0c5e3e7..30bb5013daecfc655d58cf48b142d9cc8f4c541a 100644
--- a/src/data/drug-data.tsx
+++ b/src/data/drug-data.tsx
@@ -56,7 +56,7 @@ export const drugdata: (Array<DrugDatensatz>)  = [
     {
         name: "Mucolytics and inhalation", //gibt 2 Inhalation Beispiele
         picture: "...",
-        introduction: "Mucolytics help thin and loosen the mucus in the lungs, making it easier to cough up and clear the airways. These therapies are typically administered via wet or dry inhalation, providing direct delivery to the lungs. In the case of wet inhalation, the medication is inhaled as an aqueous solution and nebulised, while in the case of dry inhalation, the medication is inhaled as a powder. [1] Key Therapies include mannitol, Pulmozyme® and hypertonic saline.",
+        introduction: "Mucolytics help thin and loosen the mucus in the lungs, making it easier to cough up and clear the airways. These therapies are typically administered via wet or dry inhalation, providing direct delivery to the lungs. In the case of wet inhalation, the medication is inhaled as an aqueous solution and nebulized, while in the case of dry inhalation, the medication is inhaled as a powder. [1] Key Therapies include mannitol, Pulmozyme® and hypertonic saline.",
         examples: [
             {
                 title: "Pulmozyme", //quelle 8
@@ -75,7 +75,7 @@ export const drugdata: (Array<DrugDatensatz>)  = [
         examples: [
             {
                 title: "TOBI", //quelle 13 + Pseudo muss kursiv
-                text: ["Active ingredient(s): Tobramycin",<>Indications: For CF patients aged 6 years and older with <i> Pseudomonas aeruginosa </i> infections </>,"Mechanism: Aminoglycoside antibiotic disrupts bacterial protein synthesis, leading to the death of the pathogen","Administration: Inhalation of antibiotic via nebuliser, typically taken twice daily in 28-day cycles","Approval: Approved by the EMA in 2011 [14]"]
+                text: ["Active ingredient(s): Tobramycin",<>Indications: For CF patients aged 6 years and older with <i> Pseudomonas aeruginosa </i> infections </>,"Mechanism: Aminoglycoside antibiotic disrupts bacterial protein synthesis, leading to the death of the pathogen","Administration: Inhalation of antibiotic via nebulizer, typically taken twice daily in 28-day cycles","Approval: Approved by the EMA in 2011 [14]"]
             },
             {
                 title: "CAYSTON", //quelle 15 + Pseudo muss kursiv